DAFNA Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-119,615
| Closed | -$11.1M | – | 98 |
|
|
2021
Q4 | $11.1M | Hold |
119,615
| – | – | 2.8% | 6 |
|
|
2021
Q3 | $7.12M | Hold |
119,615
| – | – | 1.89% | 13 |
|
|
2021
Q2 | $8.16M | Buy |
119,615
+42,900
| +56% | +$2.8M | 1.71% | 12 |
|
|
2021
Q1 | $5.32M | Sell |
76,715
-100
| -0.1% | -$7.7K | 1.26% | 23 |
|
|
2020
Q4 | $5.9M | Buy |
76,815
+1,000
| +1% | +$75K | 1.76% | 13 |
|
|
2020
Q3 | $5.67M | Sell |
75,815
-169,327
| -69% | -$11.3M | 1.84% | 14 |
|
|
2020
Q2 | $15.4M | Buy |
245,142
+65,500
| +36% | +$3.6M | 4.45% | 4 |
|
|
2020
Q1 | $7.54M | Buy |
179,642
+80,700
| +82% | +$3.7M | 3.15% | 8 |
|
|
2019
Q4 | $4.49M | Buy |
98,942
+5,000
| +5% | +$236K | 1.54% | 17 |
|
|
2019
Q3 | $4.3M | Hold |
93,942
| – | – | 1.62% | 16 |
|
|
2019
Q2 | $5.51M | Hold |
93,942
| – | – | 2.07% | 12 |
|
|
2019
Q1 | $4.21M | Hold |
93,942
| – | – | 1.82% | 17 |
|
|
2018
Q4 | $3.66M | Sell |
93,942
-4,605
| -5% | -$181K | 1.82% | 19 |
|
|
2018
Q3 | $4.54M | Buy |
98,547
+3,305
| +3% | +$134K | 1.86% | 18 |
|
|
2018
Q2 | $4.15M | Sell |
95,242
-31,500
| -25% | -$1.35M | 1.94% | 17 |
|
|
2018
Q1 | $5.01M | Buy |
+126,742
| New | +$4.93M | 2.44% | 12 |
|
|
2017
Q3 | – | Sell |
-15,550
| Closed | -$262K | – | 84 |
|
|
2017
Q2 | $262K | Buy |
+15,550
| New | +$213K | 0.19% | 63 |
|
|
2016
Q1 | – | Sell |
-38,160
| Closed | -$725K | – | 95 |
|
|
2015
Q4 | $725K | Hold |
38,160
| – | – | 0.65% | 42 |
|
|
2015
Q3 | $729K | Buy |
38,160
+19,260
| +102% | +$654K | 0.72% | 39 |
|
|
2015
Q2 | $877K | Buy |
+18,900
| New | +$820K | 0.74% | 43 |
|